The focus of work in the Neurosciences Department?s Neurobiology Laboratory at the University of the Basque Country?s Faculty of Medicine and Odontology is the investigation of the molecular and cellular bases of neurodegenerative illnesses ? those that affect the brain and the spinal cord.
Scientists from the Center for Applied Medical Research (CIMA) from the University of Navarra investigate whether cardiotrophin 1, a molecule that can be measured in blood, can be used as a diagnostic marker for hypertensive cardiopathy.
AARP hailed the Senate passage of two provisions that would improve drug safety and improve generic drug market access. The provisions were part of a Food and Drug Administration (FDA) bill that reauthorizes the prescription drug user fee programs at FDA, known as the Prescription Drug User Fee Amendments of 2007 ? or, PDUFA ? (S. 1082).
Investigators at St. Jude Children’s Research Hospital have discovered inherited variations in certain genes that make children with acute lymphoblastic leukemia (ALL) susceptible to the toxic side effects caused by chemotherapy medications.
Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin issued the following statement today regarding the importation amendment attached to the PDUFA reauthorization bill:
Maintaining high standards of safety in every aspect of health and medical services is critical to Australia?s health system.
Thousands of Australians will get better access to a range of medicines, along with improved services at their local pharmacy, thanks to new measures in this year?s Budget.
Scientists from the Center for Applied Medical Research from the University of Navarra investigate whether cardiotrophin 1, a molecule that can be measured in blood, can be used as a diagnostic marker for hypertensive cardiopathy.
Researchers at the University of Illinois at Chicago, in collaboration with research teams from Pharmacia & Upjohn and Pfizer, have discovered precisely how the antibiotic linezolid inhibits bacterial growth.
A new study in mice raises a tantalizing possibility — that humans may one day be able to eat any kind of fat they want without raising their risk of heart disease.